Literature DB >> 22139522

Novel inhibitors to Taenia solium Cu/Zn superoxide dismutase identified by virtual screening.

P García-Gutiérrez1, A Landa-Piedra, A Rodríguez-Romero, R Parra-Unda, A Rojo-Domínguez.   

Abstract

We describe in this work a successful virtual screening and experimental testing aimed to the identification of novel inhibitors of superoxide dismutase of the worm Taenia solium (TsCu/Zn-SOD), a human parasite. Conformers from LeadQuest(®) database of drug-like compounds were selected and then docked on the surface of TsCu/Zn-SOD. Results were screened looking for ligand contacts with receptor side-chains not conserved in the human homologue, with a subsequent development of a score optimization by a set of energy minimization steps, aimed to identify lead compounds for in vitro experiments. Six out of fifty experimentally tested compounds showed μM inhibitory activity toward TsCu/Zn-SOD. Two of them showed species selectivity since did not inhibit the homologous human enzyme when assayed in vitro.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22139522     DOI: 10.1007/s10822-011-9498-x

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  35 in total

Review 1.  The biochemical basis of anthelmintic action and resistance.

Authors:  P Köhler
Journal:  Int J Parasitol       Date:  2001-04       Impact factor: 3.981

Review 2.  Natural plant cysteine proteinases as anthelmintics?

Authors:  Gillian Stepek; Jerzy M Behnke; David J Buttle; Ian R Duce
Journal:  Trends Parasitol       Date:  2004-07

Review 3.  Methods for the prediction of protein-ligand binding sites for structure-based drug design and virtual ligand screening.

Authors:  Alasdair T R Laurie; Richard M Jackson
Journal:  Curr Protein Pept Sci       Date:  2006-10       Impact factor: 3.272

4.  Anatomy of protein pockets and cavities: measurement of binding site geometry and implications for ligand design.

Authors:  J Liang; H Edelsbrunner; C Woodward
Journal:  Protein Sci       Date:  1998-09       Impact factor: 6.725

5.  Inhibition of superoxide dismutase from Ascaris suum by benzimidazoles and synthesized pyrimidine and glycine derivatives.

Authors:  M Sanchez-Moreno; E Entrala; D Janssen; C Fernandez-Becerra; J M Salas-Peregrin; A Osuna
Journal:  Pharmacology       Date:  1996-01       Impact factor: 2.547

6.  Backbone dynamics of human Cu,Zn superoxide dismutase and of its monomeric F50E/G51E/E133Q mutant: the influence of dimerization on mobility and function.

Authors:  L Banci; I Bertini; F Cramaro; R Del Conte; A Rosato; M S Viezzoli
Journal:  Biochemistry       Date:  2000-08-08       Impact factor: 3.162

7.  Magnitude of the disease burden from neurocysticercosis in a developing country.

Authors:  C Bern; H H Garcia; C Evans; A E Gonzalez; M Verastegui; V C Tsang; R H Gilman
Journal:  Clin Infect Dis       Date:  1999-11       Impact factor: 9.079

8.  Solution structure of reduced monomeric Q133M2 copper, zinc superoxide dismutase (SOD). Why is SOD a dimeric enzyme?.

Authors:  L Banci; M Benedetto; I Bertini; R Del Conte; M Piccioli; M S Viezzoli
Journal:  Biochemistry       Date:  1998-08-25       Impact factor: 3.162

Review 9.  The current status of neurocysticercosis in Eastern and Southern Africa.

Authors:  N A Mafojane; C C Appleton; R C Krecek; L M Michael; A L Willingham
Journal:  Acta Trop       Date:  2003-06       Impact factor: 3.112

Review 10.  Oxygen toxicity: a radical explanation.

Authors:  I Fridovich
Journal:  J Exp Biol       Date:  1998-04       Impact factor: 3.312

View more
  1 in total

1.  Crystal structure of an extracellular superoxide dismutase from Onchocerca volvulus and implications for parasite-specific drug development.

Authors:  Amr Moustafa; Markus Perbandt; Eva Liebau; Christian Betzel; Sven Falke
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2022-05-27       Impact factor: 1.072

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.